• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN
Image of blue rendered molecular structure

IMCS at MSACL 2024

IMCS Poster Presentation Download

PO_MSACL_2024_Thumb

#25a: Enzymatic Hydrolysis of Recalcitrant Steroids with Engineered Arylsulfatases

Abstract Expand

ABSTRACT:
INTRODUCTION
Over the last decade, detecting sulfated anabolic androgenic steroids (AAS) has been described as preferred analytical methods. However, its direct detection can be limited due to poor cleavage of the sulfate, especially in testosterone and its derivative, boldenone. Poor recovery of dehydroepiandrosterone sulfate (DHEAS) has also been a major challenge in steroid testing community.

OBJECTIVE
There are no reported sulfatases that can cleave sulfated metabolites of testosterone, boldenone or dehydroepiandrosterone. These are the first reported, genetically engineered variants of sulfatases completely hydrolyze testosterone- boldenone- 17beta sulfates and DHEA-3beta sulfates.

METHODS
Steroid standards, internal standards, and sulfated metabolites were from Cerilliant, Steraloids, TRC and Fisher. Chemicals were purchased from MilliporeSigma and Fisher Scientific. Drug free human urine controls were from UTAK. Urine controls were fortified with sulfated metabolites and hydrolyzed up to 4 hours at 37°C. After hydrolysis, samples were diluted to 50% methanol and eluted through a β-Gone Plus plate from Phenomenex. 10 uL of diluted sample was injected on a Thermo Scientific® Vanquish® UHPLC system coupled to Thermo Scientific® Endura® Triple Quadrupole Mass Spectrometer using a Phenomenex Kinetex® 2.6 um Biphenyl 100 Å, 50 x 4.6 mm column. Mobile phases A and B were 0.1% formic acid in water and methanol, respectively. Calibration curves had r2 ≥ 0.99 and quality controls were within ± 20%.

RESULTS
Engineered arylsulfatases from P. aeruginosa can hydrolyze difficult substrates such as boldenone sulfate and dehydroepiandrosterone sulfate within 2 hours at 37°C, whereas all prior purified sulfatases have little or no observed activity towards these analytes.

CONCLUSION
Difference in reactivities were observed for sulfatases towards 3beta and 17beta sulfates. Milder reaction conditions were established for liberating sulfated steroids in urine. Larger, comparative studies need to be performed in a broader range of biological matrices before enzymes are recommended for routine use in steroid testing.

We systematically purified pDNA from bacterial lysates containing plasmids of different sizes (3262 – 8484 bps) using our automated method employing loosely-packed silica tips. The effectiveness of our method was benchmarked against commercially available spin plates and magnetic bead kits. Our method demonstrated higher overall recoveries when compared to magbeads and comparable yields when compared to the manual spin plate, yielding pDNA amounts between 8.92±0.62 µg and 12.28±0.24 µg. Moreover, the resulting purity compared well to alternative methods, with 260/280 and 260/230 ratios of 1.85 and 2.03 across all samples.

Overall, yields and purity were comparable to the spin-plate method. Time from sample isolation to purification was under one hour for up to 96 samples, comparable to the spin-plate method and faster than the magbead workflow (75 minutes). This work represents an adaptation of a traditional plasmid purification workflow for automated liquid handlers. Challenges such as carryover and buffer selection when the purification is automated in pipette tips are identified and how these challenges were overcome are discussed. The workflow can process 96 samples quickly (<60 minutes), while maintaining high yields (>10 µg) and excellent purity.

Download PDF
Learn More!

Sidebar

"*" indicates required fields

Name*
Email me a copy
Consent

Customize Your Workflow

IMCS recognizes our customers’ needs vary, which is why we provide tailored tools and services to help you reach your laboratory’s goals.

VIEW OUR CUSTOM SOLUTIONS

ABOUT IMCS

INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (IMCS) IS A BIOTECHNOLOGY COMPANY FOCUSED ON DELIVERING TOOLS AND SERVICES THAT HELP PAVE THE WAY FOR THE FUTURE OF PRECISION MEDICINE. WE STRIVE TO ADDRESS THE GROWING NEEDS OF CLINICAL AND RESEARCH LABORATORIES THROUGH ADVANCED TECHNOLOGIES THAT INCREASE TESTING EFFICIENCY AND ACCURACY.

STAY UP TO DATE

WANT REGULAR UPDATES ON OUR INNOVATIVE PRODUCTS?
Sign up to receive exclusive emails and offers from IMCS.
!
!
!
Subscribe
Something went wrong. Please check your entries and try again.

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

Return to top

Caleb-Schlachter-for-web

Caleb R. Schlachter, Ph.D.

Principal Scientist
Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
Gray Amick for web

Gray D. Amick, Ph.D.

Director of Operations
Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
Amanda M Headshot

Amanda C. McGee

Research Scientist
Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
Andrew_Headshot

L. Andrew Lee, Ph.D.

Co-Founder and Chief Scientific Officer
L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

Get started with 2N1 below

"*" indicates required fields

Name*
Would you be interested in joining the 2N1 beta program?*
Which product are you interested in? (select all that apply)*
What are your current purification workflows? (select all that apply)*
Please select your automation platform(s) (select all that apply)*
How soon are you planning on evaluating 2N1?*
Consent*

DOWNLOAD OUR POSTERS

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Consent*